Bionumerik pharmaceuticals acquired
WebOperating Agreement • August 24th, 2004 • Bionumerik Pharmaceuticals Inc • Services-commercial physical & biological research • Delaware WebFunding. BioNumerik Pharmaceuticals has raised a total of $63.3M in funding over 3 rounds. Their latest funding was raised on Nov 8, 2012 from a Venture - Series Unknown round. BioNumerik Pharmaceuticals is funded by Takeda. BioNumerik Pharmaceuticals has a post-money valuation in the range of $10M to $50M as of Dec 31, 2012, according …
Bionumerik pharmaceuticals acquired
Did you know?
WebCompany Description: BioNumerik Pharmaceuticals does biopharmaceutical drug development by the numbers. Using a multi-discipline process of identifying potential … WebJun 14, 2012 · SAN ANTONIO, June 14, 2012 /PRNewswire/ -- BioNumerik Pharmaceuticals, Inc. ("BioNumerik") today announced the appointment of Mr. Steve Carchedi to BioNumerik's Board of Directors.
WebJun 18, 2024 · BioNumerik Pharmaceuticals discovers, develops and commercializes drugs for treating cancer. Where We Are. 8122 Datapoint Dr San Antonio TX 78229 Workplace Type. On-site Workplace. Employees work from physical offices. Jobs At BioNumerik Pharmaceuticals. 0 Jobs All Jobs Content Data + Analytics ... WebBNP1350 (Karenitecin, BioNumerik Pharmaceuticals) non–small cell lung cancer/ovarian cancer phase 2/phase 3 bortezomib (Velcade, Millennium) adenocarcinoma, diff use large B-cell lymphoma, T-cell prolymphocytic leukemia/mantle cell lymphoma, non-Hodgkin’s B …
WebDeveloping and commercializing drugs for treating cancer BioNumerik Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drugs that help in … WebJun 14, 2012 · SAN ANTONIO, June 14, 2012 /PRNewswire/ -- BioNumerik Pharmaceuticals, Inc. ("BioNumerik") today announced the appointment of Mr. Steve Carchedi to BioNumerik's Board of Directors.. Mr. Carchedi brings extensive pharmaceutical industry and oncology product commercialization experience to the …
Web51 to 200 Employees. Type: Company - Private. Industry: Biotech & Pharmaceuticals. Revenue: $5 to $25 million (USD) Competitors: Unknown. BioNumerik Pharmaceuticals does biopharmaceutical drug development by the numbers. Using a multi-discipline process of identifying potential cancer drugs, the company has brought two candidates into late ...
WebBionumerik Pharmaceuticals designs and develops small molecule drugs for the treatment of cancer and prevention of side effects associated with existing cancer therapies. philishave 4800WebJun 14, 2012 · SAN ANTONIO, June 14, 2012 /PRNewswire/ -- BioNumerik Pharmaceuticals, Inc. ("BioNumerik") today announced the appointment of Mr. Steve … philishave 4608philishave 4806 bladesWebBioNumerik Pharmaceuticals uses 11 technology products and services including HTML5, jQuery, and Google Analytics, according to G2 Stack. BioNumerik Pharmaceuticals is actively using 4 technologies for its website, according to BuiltWith. These include GoDaddy DNS, Person Schema, and Gravatar Profiles. philishave 5425 scherkopfWebMar 18, 2008 · SAN ANTONIO and TOKYO, March 18 /PRNewswire/ -- BioNumerik Pharmaceuticals, Inc. ("BioNumerik") and ASKA Pharmaceutical Co., Ltd. ("ASKA") … try guys onesieWebAcquired Party. BioNumerik Pharmaceuticals, Inc. Granting Status. Granted. Acquired Entities. BioNumerik Pharmaceuticals, Inc. More Resources. HSR Annual Reports; … philishave 40WebThe estimated total pay for a BioNumerik Pharmaceuticals is $55,502 per year in the United States area, with an average salary of $51,532 per year. These numbers represent the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. The estimated additional pay is ... try guys no recipe road trip